Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration–Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics
- 6 April 2018
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 57 (10) , 1307-1323
Abstract
The objective of this study was to develop a physiologically based pharmacokinetic (PBPK) model for sinogliatin (HMS-5552, dorzagliatin) by integrating allometric scaling (AS), in vitro to in vivo exploration (IVIVE), and steady-state concentration–mean residence time (Css-MRT) methods and to provide mechanistic insight into its pharmacokinetic properties in humans.Keywords
Funding Information
- National Natural Science Foundation of China (81403013, 81403015)
- "13th Five-Year" National Major New Drug Projects (2017ZX09101001-002-001, 2017ZX09304031-001)
This publication has 32 references indexed in Scilit:
- Type 2 Diabetes Mellitus: A Review of Current TrendsOman Medical Journal, 2012
- Prediction of Human Oral Plasma Concentration-Time Profiles Using Preclinical DataClinical Pharmacokinetics, 2011
- CYP3A4*16 and CYP3A4*18 Alleles Found in East Asians Exhibit Differential Catalytic Activities for Seven CYP3A4 Substrate DrugsDrug Metabolism and Disposition, 2010
- A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug ClearanceClinical Pharmacokinetics, 2010
- Biophysical Characterization of the Interaction between Hepatic Glucokinase and Its Regulatory ProteinJournal of Biological Chemistry, 2008
- Physiology-Based Simulations of a Pathological ConditionClinical Pharmacokinetics, 2008
- Haplotypes ofCYP3A4 and their close linkage withCYP3A5 haplotypes in a Japanese populationHuman Mutation, 2003
- Physiological Parameter Values for Physiologically Based Pharmacokinetic ModelsToxicology and Industrial Health, 1997
- An extended physiological pharmacokinetic model of methadone disposition in the rat: Validation and sensitivity analysisJournal of Pharmacokinetics and Biopharmaceutics, 1988
- Effect of Altered Plasma Protein Binding on Apparent Volume of DistributionJournal of Pharmaceutical Sciences, 1979